Recruiting A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study) NCT06789913 Conditions Angiomatosis, CLOVES Syndrome, Cardiovascular Abnormalities, +17 more Locations Phoenix Children's Hospital — Phoenix, Arizona, United States Arkansas Children's Hospital — Little Rock, Arkansas, United States University of California, Los Angeles — Los Angeles, California, United States Stanford University — Palo Alto, California, United States View all 34 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Identification of Biomarkers for Patients with Vascular Anomalies NCT03001180 Conditions Angiomatosis, Bone Diseases, Bone Diseases, Developmental, +18 more Locations Boston Children's Hospital — Boston, Massachusetts, United States Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States View Trial Details
Completed National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS) NCT05563831 Conditions Angiomatosis, CLOVES Syndrome, Cardiovascular Abnormalities, +32 more Locations Translational medicine and Targeted therapies unit, Hôpital Necker Enfants Malades — Paris, France View Trial Details
Completed French National Cohort of Children With Port Wine Stain NCT01364857 Conditions Angiomatosis, Cardiovascular Diseases, Congenital Abnormalities, +17 more Locations Service de dermatologie — Amiens, France Service de dermatologie — Angers, France Service de dermatologie — Bordeaux, France Service de dermatologie — Caen, France View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Vascular Anomaly Pathology and Genomics Biopsy Study NCT04836884 Conditions Angiomatosis, Arteriovenous Malformations, Cardiovascular Abnormalities, +17 more Locations Mayo Clinic in Rochester — Rochester, Minnesota, United States View Trial Details
